Asclera (polidocanol) Disease Interactions
There is 1 disease interaction with Asclera (polidocanol):
Polidocanol (Includes Asclera) ↔ thromboembolic disease
Severe Potential Hazard, Moderate plausibility. Applies to: Thrombotic/Thromboembolic Disorder
Polidocanol is a sclerosing agent that locally damages the endothelium of blood vessels. When injected intravenously, polidocanol induces endothelial damage. The use of polidocanol is contraindicated in patients with acute thromboembolic diseases.
More about Asclera (polidocanol)
- Asclera Side Effects
- During Pregnancy
- Dosage Information
- Pricing & Coupons
- En Español
- Drug class: sclerosing agents
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.